Loading clinical trials...
Loading clinical trials...
64Cu-DOTA-trastuzumab Positron Emission Tomography in Patients With Gastric Cancer
Conditions
Interventions
copper Cu 64-DOTA-trastuzumab
positron emission tomography
+2 more
Locations
1
United States
City of Hope Medical Center
Duarte, California, United States
Start Date
November 19, 2014
Primary Completion Date
March 30, 2019
Completion Date
August 5, 2024
Last Updated
February 28, 2025
NCT06881017
NCT02065765
NCT02443324
NCT04773769
NCT00061932
NCT01107639
Lead Sponsor
City of Hope Medical Center
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions